Press Room

A new report by the American Cancer Society Cancer Action Network (ACS CAN) found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

BISMARCK, N.D. -- As North Dakota legislators close their first week of business for the new year, American Cancer Society Cancer Action Network advocates on Monday will ask them to take strong action to reduce the cost of fighting cancer. 

As the Colorado General Assembly convenes for its 75th regular session on Wednesday, the American Cancer Society Cancer Action Network (ACS CAN) and its team of advocates is calling on legislators to support several priorities to improve the prevention, early detection and treatment  of cancer. 

Legislation will eliminate costly barriers to follow up breast cancer screening

S.2971, An Act relative to medically necessary breast screenings and exams for equity and early detection requires that health plans regulated by the Commonwealth cover medically necessary screening and diagnostic breast imaging with no out- of-pocket costs.

The American Cancer Society (ACS) released an update this week on breast cancer occurrence and trends in the United States. While the new report finds mortality rates have dropped by 44% since 1989, not all women have benefited from this progress. The report highlighted a continued upward trend in breast cancer incidence with the steepest increase in women younger than 50 years and Asian American/Pacific Islander (AAPI) women of all ages. The release coincides with the American Cancer Society Cancer Action Network’s (ACS CAN) campaign to connect patients with the right treatment at the right time through increasing access to biomarker testing in Hawaii. 

Washington, D.C., – Emily Kalmer was recognized as the country’s top government relations professional by the American Cancer Society Cancer Action Network (ACS CAN) in honor of her exceptional work advocating for cancer-fighting public policies.

Esta semana, el Comité de asignaciones presupuestarias del Senado de los Estados Unidos examinó y aprobó su proyecto de ley de asignaciones presupuestarias para el año fiscal 2025, que incluye aumentos significativos para los Institutos Nacionales de Salud (NIH), aumentos para el financiamiento de la investigación del cáncer a nivel federal en el Instituto Nacional del Cáncer (NCI) y un aumento para la División de Prevención y Control del Cáncer de los Centros para el Control y la Prevención de Enfermedades (CDC).   

The Pennsylvania Legislature passed and Governor Shapiro certified the 2024-25 budget—the contents of which reflect a step in the right direction in the effort to end cancer as we know it for everyone.

Today, the U.S. Court of Appeals for the Fifth Circuit partially reversed a district court decision that had invalidated key provisions of the Affordable Care Act (ACA) in the case of Braidwood v. Becerra, finding cost-free preventive services could remain in place...